lorazepam has been researched along with Dyskinesia, Medication-Induced in 11 studies
Lorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neurologically intact." | 3.69 | Movement disorders associated with the use of gabapentin. ( Krahn, LE; Reeves, AL; Sharbrough, FW; So, EL, 1996) |
| "The drop in the akathisia score from a pretreatment value of 1." | 2.66 | Treatment of akathisia with lorazepam. An open clinical trial. ( Bartels, M; Heide, K; Mann, K; Schied, HW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohli, N | 1 |
| Bordeaux, JS | 1 |
| Park, YM | 1 |
| Lee, HJ | 1 |
| Kang, SG | 1 |
| Choo, CS | 1 |
| Cho, JH | 1 |
| Sekhar, S | 1 |
| Kalra, B | 1 |
| Mendhekar, DN | 1 |
| Tekur, U | 1 |
| Miller, MA | 1 |
| Levsky, ME | 1 |
| Jeffries, JJ | 1 |
| Northoff, G | 2 |
| Wenke, J | 2 |
| Pflug, B | 2 |
| Reeves, AL | 1 |
| So, EL | 1 |
| Sharbrough, FW | 1 |
| Krahn, LE | 1 |
| Demisch, L | 1 |
| Eckert, J | 1 |
| Gille, B | 1 |
| Stevens, E | 1 |
| Roman, A | 1 |
| Houa, M | 1 |
| Razavi, D | 1 |
| Jaspar, N | 1 |
| Bartels, M | 1 |
| Heide, K | 1 |
| Mann, K | 1 |
| Schied, HW | 1 |
| Sandyk, R | 1 |
3 trials available for lorazepam and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol | 2010 |
Catatonia: short-term response to lorazepam and dopaminergic metabolism.
Topics: Acute Disease; Adult; Anti-Anxiety Agents; Anxiety; Catatonia; Depressive Disorder; Dopamine; Dyskin | 1995 |
Treatment of akathisia with lorazepam. An open clinical trial.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Clinical Trials as Topic; Dyskinesia, Drug-Ind | 1987 |
8 other studies available for lorazepam and Dyskinesia, Medication-Induced
| Article | Year |
|---|---|
Involuntary movements during periocular reconstruction secondary to lorazepam.
Topics: Aged, 80 and over; Anti-Anxiety Agents; Blepharoplasty; Dyskinesia, Drug-Induced; Humans; Lorazepam; | 2015 |
Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
Topics: Aged; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Benzamides; Benzyl Compounds; B | 2009 |
Choreiform dyskinesia following isolated lamotrigine overdose.
Topics: Adult; Anticonvulsants; Antimanic Agents; Bipolar Disorder; Chorea; Drug Overdose; Dyskinesia, Drug- | 2008 |
Treatment of acute neuroleptic-induced dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Lorazepam | 1983 |
Increase of serum creatine phosphokinase in catatonia: an investigation in 32 acute catatonic patients.
Topics: Acute Disease; Adult; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Creatine Kinase; D | 1996 |
Movement disorders associated with the use of gabapentin.
Topics: Acetates; Adult; Amines; Anticonvulsants; Benzodiazepines; Cyclohexanecarboxylic Acids; Dyskinesia, | 1996 |
Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.
Topics: Anti-Anxiety Agents; Anti-Dyskinesia Agents; Antidepressive Agents, Second-Generation; Antidepressiv | 1998 |
Orofacial dyskinesias associated with lorazepam therapy.
Topics: Anxiety Disorders; Depressive Disorder; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Lo | 1986 |